Highlighted Article

 

Debu Tripathy, et al., The Oncologist

The SystHERs breast cancer study was a fully enrolled, prospective registry study that explored contemporary treatment patterns and outcomes in patients with HER2-positive metastatic breast cancer (MBC), resulting in one of the largest real-world datasets for this population and providing a unique opportunity to assess patients with de novo and recurrent HER2-positive MBC. This article reports baseline characteristics, treatment patterns, patient-reported outcomes, and clinical outcomes in these patient subsets.
 

Dr. Don DizonDiscussions with Don S. Dizon, MD

Don S. Dizon is the Director of Women's Cancers at Lifespan Cancer Institute, Founder of The Oncology Sexual Health First Responders Clinic at Lifespan Cancer Institute, and Director of Medical Oncology at Rhode Island Hospital. Dr. Dizon is a Professor of Medicine at the Warren Alpert Medical School of Brown University.

 

12/10/19
A cancer diagnosis is often frightening, even devastating. But the journey from diagnosis through treatment can also be transformative. In this month’s blog, Carolyn Taylor shares with Don Dizon her experience with cancer and how it led to a new-found dedication to global cancer advocacy.
11/12/19
In this month's blog post, Don Dizon and Aditya Bardia discuss the bonds that form not only between physicians and their patients but also with their caregivers during the emotional experience of cancer treatment.
10/03/19
Don Dizon and Charles Blanke discuss how they approach social media, the public, and their patients in this month's blog post.